Quinn MA - Search Results

1

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.

Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. Brown AK, et al. Among authors: quinn ma. Arthritis Rheum. 2008 Oct;58(10):2958-67. doi: 10.1002/art.23945. Arthritis Rheum. 2008. PMID: 18821687 Free article.

2

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, Gough AK, Green MJ, Helliwell PS, Keenan AM, Morgan AW, Quinn M, Reece R, van der Heijde DM, Wakefield RJ, Emery P. Nam JL, et al. Ann Rheum Dis. 2014 Jan;73(1):75-85. doi: 10.1136/annrheumdis-2013-203440. Epub 2013 Aug 2. Ann Rheum Dis. 2014. PMID: 23912798 Clinical Trial.

3

Overexpression of transcripts containing LINE-1 in the synovia of patients with rheumatoid arthritis.

Ali M, Veale DJ, Reece RJ, Quinn M, Henshaw K, Zanders ED, Markham AF, Emery P, Isaacs JD. Ali M, et al. Ann Rheum Dis. 2003 Jul;62(7):663-6. doi: 10.1136/ard.62.7.663. Ann Rheum Dis. 2003. PMID: 12810431 Free PMC article.

4

Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study.

Haugeberg G, Conaghan PG, Quinn M, Emery P. Haugeberg G, et al. Ann Rheum Dis. 2009 Dec;68(12):1898-901. doi: 10.1136/ard.2008.106484. Epub 2009 Apr 21. Ann Rheum Dis. 2009. PMID: 19386610 Clinical Trial.

5

Treatment of rheumatoid arthritis 2001.

Emery P, Conaghan P, Quinn M. Emery P, et al. J Rheumatol. 2001 Jun;28(6):1201-2. J Rheumatol. 2001. PMID: 11409108 No abstract available.

6

Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?

Saleem B, Mackie S, Quinn M, Nizam S, Hensor E, Jarrett S, Conaghan PG, Emery P. Saleem B, et al. Ann Rheum Dis. 2008 Aug;67(8):1178-80. doi: 10.1136/ard.2007.084269. Epub 2008 Jan 30. Ann Rheum Dis. 2008. PMID: 18234715 Clinical Trial.

7

Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?

Conaghan PG, Quinn MA, O'Connor P, Wakefield RJ, Karim Z, Emery P. Conaghan PG, et al. Among authors: quinn ma. Arthritis Rheum. 2002 Jul;46(7):1971-2; author reply 1973. doi: 10.1002/art.10274. Arthritis Rheum. 2002. PMID: 12124886 Free article. No abstract available.

8

Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.

Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P. Jarrett SJ, et al. Among authors: quinn ma. J Rheumatol. 2003 Oct;30(10):2287-91. J Rheumatol. 2003. PMID: 14528531

9

Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis.

Bejarano V, Conaghan PG, Quinn MA, Saleem B, Emery P. Bejarano V, et al. Among authors: quinn ma. Rheumatology (Oxford). 2010 Oct;49(10):1971-4. doi: 10.1093/rheumatology/keq194. Epub 2010 Jul 1. Rheumatology (Oxford). 2010. PMID: 20595536 Clinical Trial.

10

Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.

Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P. Wakefield RJ, et al. Among authors: quinn ma. Arthritis Rheum. 2007 Dec 15;57(8):1564-7. doi: 10.1002/art.23097. Arthritis Rheum. 2007. PMID: 18050231 Free article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results